Skip to main content

Life Sciences Opportunity at ACTREC

Post-graduation preferably in Life sciences Minimum of 2 years of relevant experience in project management, computer skills, etc.
Natco Pharma Walk in Drive for D.Pharm, B.Pharm, MSc in Production, QC and Microbiology
D.Pharm, B.Pharm, M.Sc, B.Sc; Supervision of Manufacturing, Compounding, Filling, Filtration and Packing areas. Hands-on experience in Manufacturing and Compounding processes.
Stanford University opening for Life Science Research Professional
Prefer an advanced degree in the Biological Sciences, Master degree. Stanford University
VCU School of Pharmacy require Postdoctoral Fellow
PhD degree in organic synthesis, or synthetic medicinal chemistry, or pharmaceutical sciences. Strong communication skills. Virginia Commonwealth University
Zydus Lifesciences Hiring for Vaccine Technology Centre
M.Sc. in Biochemistry, Biotechnology, Microbiology, Life sciences. Upstream process operations such as seed germination, Fermenter operations, Harvest, Centrifugation.
Walk in Drive for M.Pharm, B.Pharm, MSc in Injectables Manufacturing at Amneal Pharma
ITI / Diploma / B.Sc / B.Pharm / M.Sc / M.Pharm / B.E candidates experience in Injectable regulated manufacturing plant. Amneal Pharma
Walk in Drive for D.Pharm, B.Pharm, M.Pharm in QA, QC, Manufacturing at Ipca Laboratories
M.Pharm / B.Pharm / D.Pharm ; Operating and Supervlson of Compression, Granulation & Coating machine like Fette. Glatt, Ganson, Imprinting etc.
Aurigene Oncology Hiring Senior Scientist in Medicinal Chemistry
Must have hands on experience in linker- payload synthesis and overall understanding of ADC. Should be able to design and execute synthesis of complex drug linkers and ADC payloads.
Zydus plans to acquire Agenus U.S. manufacturing facilities
Zydus Lifesciences Ltd. announced its entry into the global biologics contract development and manufacturing organization
Dapagliflozin found beneficial in fatty liver
Dapagliflozin shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), with or without type 2 diabetes in a new clinical trial conducted in China.